Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Blood|September 1, 1994
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study GroupG F Gjerset, M C Pike, J W Mosley, et al.
Blood|August 15, 1993
Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study GroupJ Hassett, G F Gjerset, J W Mosley, et al.
American Journal of Public Health|February 1, 1990
HIV seropositivity of needles from shooting galleries in south FloridaD D Chitwood, C B McCoy, J A Inciardi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 26, 2007
Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccineJ Aristegui, E Bernaola, I Pocheville, et al.
AIDS Research and Human Retroviruses|February 10, 1996
Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndromeR De Gasperi, M Angel, G Sosa, et al.
Clinical and Diagnostic Laboratory Immunology|May 30, 1998
A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visitsK Goodkin, D J Feaster, D Asthana, et al.
ACS Medicinal Chemistry Letters|September 18, 2020
Discovery of Vixotrigine: A Novel Use-Dependent Sodium Channel Blocker for the Treatment of Trigeminal NeuralgiaDavid R Witty, Giuseppe Alvaro, Dominique Derjean, et al.
Medicine and Science in Sports and Exercise|July 23, 1999
Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infectionF M Perna, A LaPerriere, N Klimas, et al.
Neurogastroenterology and Motility|April 21, 2009
GSK962040: a small molecule, selective motilin receptor agonist, effective as a stimulant of human and rabbit gastrointestinal motilityG J Sanger, S M Westaway, A A Barnes, et al.
Journal of Medicinal Chemistry|February 5, 2009
Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidateSusan M Westaway, Samantha L Brown, Stephen C M Fell, et al.
Pageof 15